• study
  • If you are found to be eligible to take part in this study, you will receive pentostatin through a central venous catheter in your vein once a week for 4 weeks and then every 2 weeks until the achievement of best response. (clinicaltrials.gov)
  • PURPOSE: Phase I/II trial to study the effectiveness of pentostatin followed by peripheral stem cell transplantation in treating patients who have advanced kidney cancer. (clinicaltrials.gov)
  • determine
  • Determine the duration and efficiency of hematopoietic and immunologic engraftment in patients with advanced renal cell carcinoma treated with pentostatin followed by related allogeneic stem cell transplantation. (clinicaltrials.gov)
  • Important
  • When you are receiving pentostatin, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. (drugs.com)